Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2025-09-23
DOI
https://doi.org/10.1016/j.ebiom.2025.105940
Citations
2
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
2.33
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study

Emma Fiorini, Michael Jonsson, Marija Vukicevic, Anne Börjesson‐Hanson et al.
2 citations
EBioMedicine
Alzheimer's disease research and treatments
2.33
article

Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study

Emma Fiorini, Michael Jonsson, Marija Vukicevic, Anne Börjesson‐Hanson, Johannes Streffer, Iva Kezic, Philip Scheltens, Julien Mermoud, Eva S. Gollwitzer, Bénédicte Lê, Sudhir Kurl, V. R. Gerasymchuk, Julian Gray, Gallen Triana‐Baltzer, Clara Theunis, David T. Hickman, Catherine J. Mummery, Catherine Pennington, Valérie Hliva, Karen A. Ritchie, P. L. J. Dautzenberg, Everard G.B. Vijverberg, Jonathan Wagg, Juha O. Rinne, Nicolas Fournier, Olivier Sol, Marie Kosco‐Vilbois, Merja Hallikainen, Andréa Pfeifer, Lennert Steukers
article en
2 citations

Abstract

No abstract available for this paper.
EBioMedicineVol. 120
Johnson & Johnson (United States) (US), Karolinska University Hospital (SE), University of Antwerp (BE), University of Eastern Finland (FI), Sahlgrenska University Hospital (SE), Turku University Hospital (FI), AC Immune (Switzerland) (CH), Turku PET Centre (FI), Amsterdam University Medical Centers (NL), Robert Bosch (Netherlands) (NL), University College London (GB), University of Gothenburg (SE), University of Edinburgh (GB)
Openalex Percentile: Top 10%
Alzheimer's disease research and treatments
2.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.